2-8°C (after addition of conserving agent), extended storage at -20°C, avoid repeated freeze-thaw cycles
Kounnas, Argraves, Strickland: "The 39-kDa receptor-associated protein interacts with two members of the low density lipoprotein receptor family, alpha 2-macroglobulin receptor and glycoprotein 330." in: The Journal of biological chemistry, Vol. 267, Issue 29, pp. 21162-6, (1992) (PubMed).
Target
LRPAP1
(Low Density Lipoprotein Receptor-Related Protein Associated Protein 1 (LRPAP1))
wu:fi20f07 antikoerper, wu:fi22c06 antikoerper, LRPAP1 antikoerper, DKFZp459I2430 antikoerper, A2MRAP antikoerper, A2RAP antikoerper, HBP44 antikoerper, MRAP antikoerper, RAP antikoerper, AA617339 antikoerper, AI790446 antikoerper, AU042172 antikoerper, C77774 antikoerper, alpha-2-macroglobulin receptor-associated protein-like antikoerper, low density lipoprotein receptor-related protein associated protein 1 antikoerper, LDL receptor related protein associated protein 1 antikoerper, LDL receptor related protein associated protein 1 L homeolog antikoerper, LOC100231803 antikoerper, lrpap1 antikoerper, LRPAP1 antikoerper, Lrpap1 antikoerper, lrpap1.L antikoerper
Hintergrund
7F1 reacts with the 39 kDa RAP protein, which is cosynthesized with human LRP/ α 2 MR (low density lipoprotein receptor-related protein / α 2 -macro- globulin receptor). It inhibits the binding of ligands, e.g. tPA, uPA, VLDL, liproprotein lipase, and α 2